Alkermes plc
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products …
Biotechnology
IE, Dublin [HQ]
Cash Flow Statements
14 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Cash Flow (OCF) | -12.00 | -5.00 | -2.00 | 126.00 | 11.00 | -40.00 | -63.00 | 19.00 | 99.00 | 72.00 | 82.00 | 101.00 | 21.00 | 401.00 | |
| Operating Cash (Net) | -12.00 | -5.00 | -2.00 | 126.00 | 11.00 | -40.00 | -63.00 | 19.00 | 99.00 | 72.00 | 82.00 | 101.00 | 21.00 | 401.00 | |
| Accounts Receivable | - - | -14.00 | - - | -14.00 | -17.00 | -16.00 | -35.00 | -42.00 | -58.00 | 35.00 | -18.00 | -38.00 | 25.00 | -44.00 | |
| Accounts Payable | - - | - - | - - | - - | 56.00 | 76.00 | 45.00 | 72.00 | 46.00 | 27.00 | 59.00 | 43.00 | 15.00 | 23.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | -15.00 | 8.00 | -1.00 | -15.00 | 10.00 | 81.00 | -27.00 | -4.00 | -7.00 | 65.00 | 13.00 | -25.00 | 12.00 | -36.00 | |
| Other WC | -11.00 | 3.00 | 3.00 | -8.00 | 2.00 | 2.00 | - - | 25.00 | 7.00 | 16.00 | -4.00 | -6.00 | 2.00 | -12.00 | |
| Investing Activities | |||||||||||||||
| Used Cash (Net) | 28.00 | 5.00 | -417.00 | -68.00 | -263.00 | -43.00 | 127.00 | -18.00 | -22.00 | -141.00 | -11.00 | -66.00 | -64.00 | 53.00 | |
| Capital Expenditure | -15.00 | -9.00 | -16.00 | -22.00 | -33.00 | -52.00 | -43.00 | -51.00 | -69.00 | -90.00 | -42.00 | -29.00 | -38.00 | -48.00 | |
| Purchases of Investments | -465.00 | -370.00 | -228.00 | -303.00 | -642.00 | -508.00 | -375.00 | -431.00 | -397.00 | -277.00 | -229.00 | -340.00 | -309.00 | -254.00 | |
| Sale/Maturity of Investment | 516.00 | 385.00 | 323.00 | 258.00 | 341.00 | 467.00 | 560.00 | 464.00 | 444.00 | 224.00 | 253.00 | 295.00 | 281.00 | 355.00 | |
| Property, Plant, Equipment (P&PE) | -15.00 | -9.00 | -16.00 | -22.00 | -33.00 | -52.00 | -43.00 | -51.00 | -69.00 | -90.00 | -42.00 | -29.00 | -38.00 | -48.00 | |
| Acquisitions (Net) | -8.00 | - - | -494.00 | - - | 27.00 | 50.00 | -15.00 | - - | - - | -8.00 | 2.00 | - - | - - | - - | |
| Other Investing Activities | - - | - - | - - | -1.00 | 44.00 | 50.00 | - - | - - | - - | 10.00 | 4.00 | 8.00 | 1.00 | 101.00 | |
| Financing Activities | |||||||||||||||
| Used Cash (Net) | -23.00 | -40.00 | -464.00 | -45.00 | -308.00 | -40.00 | -58.00 | -4.00 | -1.00 | -6.00 | -2.00 | -29.00 | -1.00 | -289.00 | |
| Debt Repayment | -23.00 | -45.00 | - - | -449.00 | -6.00 | -6.00 | -65.00 | -3.00 | -2.00 | -2.00 | -2.00 | -2.00 | -3.00 | -3.00 | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
5 | 8 | - - | 11 | 261 | 44 | 33 | 39 | 40 | 28 | 16 | 41 | 37 | 45 | |
| Issued | 2.00 | 4.00 | 17.00 | - - | 248.00 | 19.00 | 20.00 | 23.00 | 20.00 | 18.00 | 8.00 | 25.00 | 19.00 | 16.00 | |
| Repurchased | -2.00 | -3.00 | - - | -11.00 | -12.00 | -25.00 | -13.00 | -16.00 | -19.00 | -9.00 | -7.00 | -16.00 | -18.00 | -28.00 | |
| Other Financing Activities | - - | 464.00 | 448.00 | 404.00 | 67.00 | 47.00 | 7.00 | 7.00 | - - | 9.00 | - - | 31.00 | 1.00 | -303.00 | |
| Cash Balances | |||||||||||||||
| Begin of Period | 86.00 | 79.00 | 38.00 | 83.00 | 167.00 | 224.00 | 181.00 | 186.00 | 191.00 | 266.00 | 203.00 | 272.00 | 337.00 | 292.00 | |
| End of Period | 79.00 | 38.00 | 83.00 | 96.00 | 224.00 | 181.00 | 186.00 | 191.00 | 266.00 | 203.00 | 272.00 | 337.00 | 292.00 | 457.00 | |
| Change | -7.00 | -40.00 | 45.00 | 13.00 | 56.00 | -42.00 | 5.00 | 4.00 | 75.00 | -62.00 | 69.00 | 64.00 | -45.00 | 164.00 | |
| Non-Cash Balances | |||||||||||||||
| Depreciation and Amortization | 25.00 | 8.00 | 93.00 | 73.00 | 98.00 | 85.00 | 94.00 | 98.00 | 103.00 | 80.00 | 81.00 | 78.00 | 77.00 | 72.00 | |
| Stock Based Compensation | - - | 28.00 | - - | 41.00 | 59.00 | 97.00 | 94.00 | 83.00 | 105.00 | 100.00 | 90.00 | 87.00 | 94.00 | 100.00 | |
| Other | 3.00 | 1.00 | 4.00 | 10.00 | -108.00 | -40.00 | -7.00 | -7.00 | 26.00 | 22.00 | -1.00 | 4.00 | 27.00 | -154.00 | |
| Highlighted metrics | |||||||||||||||
| Free Cash Flow (FCF) | -28.00 | -15.00 | -19.00 | 104.00 | -22.00 | -93.00 | -107.00 | -32.00 | 29.00 | -18.00 | 40.00 | 72.00 | -17.00 | 353.00 | |
| Cash Conversion Cycle (CCC) | 143.00 | 122.00 | 151.00 | 108.00 | 104.00 | 91.00 | 105.00 | 118.00 | 130.00 | 107.00 | 152.00 | 158.00 | 346.00 | 225.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
|||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -164.00 |